Skip to main content
WBF What is
brain fog?
Support WBF Take quiz

Test guide Blood test

Testosterone Blood Test

Check why you had the test and whether it shows total, free, or bioavailable testosterone. Interpret that measurement using age, sex, collection time, medicines, symptoms, and the laboratory method.

Adult male diagnosis Two accurate early-morning results plus compatible signs or symptoms Common US threshold About 300 ng/dL, not a universal optimum Ranges change Age, sex, puberty, assay, unit, illness, medicines, and timing matter
01

What a testosterone blood test can show

A testosterone report needs the reason for testing. The same value means something different for sexual symptoms, new facial hair and irregular periods, puberty, or hormone treatment. Time of day, fasting, illness, sleep, medicines, binding proteins, and the lab method also affect the result. Confirm what the lab measured. Decide if a repeat or different test would change care.

Measurement

Was total, free, or bioavailable testosterone measured?

The test name tells you which part of blood testosterone the lab reported and which range to use.

Reason for testing

Was the test looking for low production or androgen excess?

Signs and follow-up tests differ for men's low testosterone, women's excess male hormones, puberty, fertility, and treatment checks.

Collection conditions

Could timing, illness, medicines, or binding proteins change the result?

Before the result can support any diagnosis, check the conditions when the blood was drawn and the lab's method.

What one testosterone result cannot prove

It can't diagnose hypogonadism, PCOS, a pituitary or adrenal disorder, early or delayed puberty, infertility, or a cause of brain fog by itself. It cannot show that testosterone treatment or a booster will improve energy, mood, memory, or concentration.

Save this test

Save the value, unit, range, collection time, and test method

Keep the number with the measurement type, method, timing, symptoms, medicines, life stage, paired hormones, and the decision it is meant to change.

My Fog stores the details you enter. It cannot confirm a hormone condition, choose treatment, or turn a testosterone value into an explanation for brain fog.

02

Who needs a different testosterone comparison

Testosterone changes across infancy, puberty, adult life, pregnancy, illness, and aging. Sex, the clinical question, collection conditions, binding proteins, medicines, and the assay all affect which comparison is useful.

Babies, children, and teenagers

A result may be used for selected early or delayed puberty, growth, adrenal, gonadal, or developmental questions. Use pediatric age, sex, and pubertal-stage ranges. The wide changes during infancy and puberty make an adult cutoff unsafe.

Adult men

The strongest signs are sexual or reproductive changes. These include lower sex drive, fewer natural erections, infertility, small testes, unexplained anemia, or lower bone density. Fatigue, low mood, poor sleep, and concentration trouble have many other causes. Use symptoms and correctly repeated results.

Adult women

Testing can help with signs of high androgen levels. These include new facial hair, worse acne, scalp hair loss, irregular or missing periods, fertility problems, and voice changes. Low testosterone alone is not an accepted explanation for brain fog or low energy.

Pregnancy, postpartum, and breastfeeding

Hormone production and binding change, and nonpregnant intervals may not apply. Pregnancy possibility also changes the safety of androgen exposure and the causes considered. Keep pregnancy and birth timing, feeding, periods, medicines, supplements, and symptoms with the result.

Perimenopause and after menopause

Lower values can occur with age, while new rapid androgen signs after menopause need their own assessment. Testosterone changed with age in a 2026 study of selected healthy women, but no single value diagnoses menopause problems or explains thinking changes.

Older men

Testosterone often declines over adult life, but the July 2026 Endocrine Society statement uses the same symptoms-plus-confirmed-low-results approach for older and younger men. Getting older alone does not create a diagnosis or prove that treatment will improve energy, mood, memory, or brain fog.

03

What to do before the testosterone appointment

Read the order before the appointment. Check whether it says total testosterone, free testosterone, bioavailable testosterone, SHBG, or a panel. These tests are related but don't measure the same thing.

For suspected male hypogonadism, ask for the collection plan. Current Endocrine Society guidance specifies a morning fasting total testosterone measurement and confirmation with a repeat morning fasting sample. The AUA also requires two early-morning total results on separate occasions.

Do not deliberately test during an acute illness if the question can safely wait. Fever, infection, surgery, poor intake, and recovery can temporarily lower testosterone. If you can't delay the test, save the illness and recovery dates.

Save your usual wake time and whether you work nights. A clock time is less useful without the sleep schedule, especially when an early-morning result is being used in an adult male low-testosterone assessment.

Bring every prescription, injection, gel, cream, pellet, fertility medicine, supplement, and bodybuilding product. Include testosterone, DHEA, anabolic steroids, opioids, and glucocorticoids. Also include medicines that contain estrogen, anticonvulsants, thyroid treatment, and anything sold as a testosterone booster. Do not stop a prescribed product unless its prescriber gives you a plan.

Tell the clinician why the test is being done. Include sexual or fertility changes, periods, acne, hair or breast changes, testicular symptoms, puberty timing, headaches, and vision changes. Say how quickly anything changed.

Ask the lab or clinician about fasting and medicine instructions for every test in the order. Healthdirect says labs usually draw the blood in the morning, and you may need to fast. Local laboratory instructions can differ.

For a child or teenager, use a pediatric laboratory and a clinician who can interpret age, sex, growth, and pubertal stage. Do not compare the result with an adult internet range.

01

Name the measurement

Find total, free, calculated free, bioavailable, or another named result. Save any method and unit the report shows.

02

Match the result to the reason for testing

Low-testosterone symptoms in men, androgen-excess signs in women, puberty, fertility, and treatment monitoring follow different pathways.

03

Check timing and temporary influences

Keep collection time, fasting status, wake time, acute illness, hard training, calorie restriction, medicines, and hormone products with the number.

04

Use the report's own interval first

Copy the lower and upper limits, age and sex band, assay or method, and any laboratory comment. Do not replace them with one online target.

05

Ask what would change the conclusion

The next step may be a repeat total result or a reliable free testosterone test. Other options include SHBG, LH, FSH, prolactin, pregnancy testing, an androgen panel, or a review of sleep, nutrition, illness, and medicines.

04

How to read a testosterone result

Start with the exact measurement, laboratory interval, unit, method, age and sex band, and collection time. Then use the path that matches the reason for testing.

The report is missing needed context

The measurement, unit, interval, method, age or sex band, collection time, or reason for testing is missing

The result is not ready to interpret. Retrieve the full report and order before deciding that the value is low, high, or normal.

The result is inside the matching interval

Inside the reporting laboratory's matching interval

This makes a large abnormality less likely for that method and context. It does not show that testosterone explains or does not explain every symptom, and it does not end a wider brain-fog assessment.

The result is low in a man tested for low testosterone

Below the matching interval in a man being assessed for deficiency

If compatible signs or symptoms are present, the next step is usually confirmation under the recommended conditions. After a repeat confirms it, your clinician can look for the cause using LH, FSH, prolactin, SHBG or free testosterone, medicines, illness, fertility plans, and examination.

The result is high in a woman

Above the matching interval in a woman

The speed and type of change help separate PCOS from other causes. Also check test quality, periods, possible pregnancy, medicines, total and free testosterone, SHBG, DHEA-S, and selected ovarian or adrenal tests.

The result is high in another context

Clearly high for the person's age and sex or for the stated treatment plan

Confirm the specimen, timing, assay, medicines, supplements, and any prescribed hormone schedule. The question may be about hormone products, treatment checks, puberty, testicular or adrenal production, or a lab problem, not one shared diagnosis.

The same sample can look different across methods

Borderline results need the laboratory and assay attached. CDC certifies named methods against a reference procedure, while current guidelines warn that nonstandardized assays can classify the same sample differently. A repeat should keep method and timing as comparable as possible.

See research details

Every number below stays attached to the population, method, and clinical question that produced it.

SourceTotal, free, and bioavailable testosterone answer different parts of the question ContextMedlinePlus describes total testosterone as bound plus unbound hormone, free testosterone as the unattached fraction, and bioavailable testosterone as free plus hormone loosely bound to proteins other than SHBG. Total testosterone is the most common starting measurement.

Do not compare a free-testosterone value with a total-testosterone range. If the report only says testosterone, ask which measurement and method were used.

SourceCurrent US male diagnosis uses symptoms and repeated morning results ContextThe Endocrine Society's July 2026 statement requires symptoms plus consistently low accurately measured testosterone and at least two early-morning fasting tests. It calls about 300 ng/dL a common clinical threshold. The AUA also requires two early-morning total measurements and states that a value below 300 ng/dL alone does not define testosterone deficiency.

Keep the number with the actual signs or symptoms and both samples. Do not turn 300 ng/dL into a wellness target or use it for women, children, or treatment monitoring.

SourceOne current US reference study produced 264 to 916 ng/dL ContextTravison and colleagues harmonized four US and European cohorts. In 9,054 community-dwelling men, the interval for healthy nonobese men aged 19 to 39 was 264 to 916 ng/dL, with a median of 531. Labcorp currently uses 264 to 916 ng/dL for its adult male tandem mass-spectrometry test based on that work.

This range comes from one study group and method. It isn't every man's target. Obesity, health selection, age, assay, symptoms, and the clinical decision still matter.

SourceCurrent laboratories publish visibly different intervals ContextMedlinePlus gives current examples of 249 to 836 ng/dL for males aged 17 to 50 and 8.4 to 48.1 ng/dL for females aged 17 to 50. Mayo's current mass-spectrometry page lists 240 to 950 ng/dL for males aged 19 and older and 8 to 60 ng/dL for females aged 19 and older. SA Pathology lists 8 to 30 nmol/L for males aged 16 and older, 0.2 to 2.0 nmol/L for females aged 18 to 54, and 0 to 1.49 nmol/L from age 55.

These are examples from named services. Use the interval and unit printed by the laboratory that performed the test, and do not mix ng/dL with nmol/L without a checked conversion.

SourceAssay quality can change whether the same sample looks low or normal ContextCDC's April 2026 HoSt list certifies specific total-testosterone procedures across 2.50 to 1,000 ng/dL when their mean bias is within plus or minus 6.4 percent of the CDC reference method. The Endocrine Society says nonstandardized assays can classify the same sample differently.

If a result is unexpected, borderline, or compared across labs, keep the method and lab visible. Ask whether a CDC-certified or otherwise well-validated method was used for the concentration range in question.

SourceAcute illness can produce a temporary low result ContextThe AUA guideline reports a mean total-testosterone decline of about 10 percent during acute respiratory illness in a small study of young men, with declines up to 30 percent in some cohorts. It recommends avoiding diagnostic measurement during acute illness when possible.

Save the illness and recovery dates. A repeat after recovery may answer the question better than treating a temporary value.

SourceWomen need an androgen-excess pathway, not the adult male low-T pathway ContextThe 2023 international PCOS guideline recommends accurate total and free testosterone for biochemical hyperandrogenism, prefers tandem mass spectrometry over direct immunoassay for total testosterone, and warns that combined oral contraceptives can make androgen assessment difficult by raising SHBG and reducing androgen production.

Do not stop contraception on your own. If testing is important, the clinician should decide whether and how to handle medicine changes, pregnancy prevention, timing, and other causes.

SourceChildren and teenagers require puberty-specific ranges ContextMayo's current mass-spectrometry page shows why one pediatric range fails. Male values span less than 7 to 20 ng/dL at ages 6 months to 9 years, less than 7 to 800 at ages 12 to 13, and 300 to 1,200 at ages 17 to 18. Female age and Tanner-stage intervals follow a different course.

Use the child's age, sex, growth, Tanner stage when assessed, symptoms, and pediatric method. A wide developmental interval cannot label puberty early, delayed, or typical by itself.

SourceA 2026 female reference study adds information, not a universal range ContextWainwright and colleagues analyzed capillary serum results from 5,323 women aged 19 to 59 with regular cycles, normal BMI, and no reported reproductive condition. Mean testosterone declined and variation increased with age. Several authors were employees or founders of the private testing company that supplied the data.

The study supports reading results by age but doesn't replace your lab's vein-blood range, settle method differences, or diagnose why a result is high.

SourceThe newest male review keeps the diagnosis narrow ContextAnawalt and colleagues' 2026 JAMA review reports that pathological hypothalamic, pituitary, or testicular hypogonadism affects less than 1 percent of adult men, while obesity-associated low testosterone is estimated at 2 to 8 percent. It confirms hypogonadism with at least two fasting samples collected from 7 to 10 am using an accurate quality-controlled assay.

A common low value in an unwell or metabolically stressed population is not automatically permanent gland failure. Retest to confirm it's low, and look for causes before treatment.

SourceLow testosterone does not prove a cognitive treatment target ContextKnight and colleagues' 2026 preregistered randomized trial included 1,000 adult men. A single intranasal testosterone dose did not significantly improve cognitive-reflection performance compared with placebo. This task is not the same as chronic brain fog, but the null result challenges simple claims that raising testosterone directly sharpens thinking.

Do not use this study to rule treatment in or out for diagnosed hypogonadism. Use it to keep a blood result from becoming proof that testosterone caused brain fog or that a booster will fix cognition.

SourceObesity-related low testosterone can be reversible ContextThe Endocrine Society's July 2026 statement says weight loss is usually first-line when appropriately diagnosed hypogonadism is attributed to overweight or obesity and no other cause is found. Friedl and colleagues' 2026 review describes low testosterone as a phenotype that often occurs with visceral adiposity rather than proving irreversible testicular failure.

This does not make weight loss a universal prescription or a reason for crash dieting. The clinician should first confirm the diagnosis, rule out other causes, and choose a safe plan for the person's health and nutrition status.

05

What you can do before and after a testosterone result

There is no single food, supplement, workout, or sleep trick that safely raises testosterone for everyone. Useful action protects the next measurement, addresses reversible strain, and keeps other explanations open.

Keep a short symptom and timing record

For two weeks, note wake time, sleep length, shift work, sexual or period changes, exercise, food restriction, illness, alcohol, medicines, and concentration problems. Tell your clinician which tasks suffer, like losing track while driving or missing steps at work.

Protect sleep and recovery

Use a regular sleep opportunity where possible and investigate loud snoring, witnessed breathing pauses, morning headache, or severe daytime sleepiness. Better sleep supports health and a cleaner morning test, but it is not a guaranteed testosterone treatment.

Eat enough and avoid a crash plan

Use regular, tolerated food and enough energy for your activity. Severe restriction, rapid weight loss, and overtraining can disturb reproductive hormones. If weight loss is medically right for confirmed obesity-related low testosterone, choose a lasting, personal plan over fasting, detoxes, or a testosterone diet.

Use steady movement if it is safe for you

Resistance and aerobic activity can support sleep, strength, insulin sensitivity, mood, and metabolic health. Choose a level you can recover from. Do not judge the plan by whether one testosterone value rises or train hard before the blood draw to change the result.

Review medicines and hormone products openly

Bring labels and exact last-use times for opioids, prednisone-type steroids, testosterone, DHEA, anabolic steroids, fertility or estrogen medicines, and boosters. Ask if each could change the result, fertility, symptoms, or next test. Do not stop it without the prescriber.

Keep competing causes in the workup

Ask whether sleep apnea, anemia, thyroid disease, depression, medication effects, diabetes, kidney or liver illness, undernutrition, pregnancy, or another endocrine problem fits the symptoms better. Let the hormone result narrow the question while you check more likely causes.

What one hormone number should not start

Do not buy or change testosterone, DHEA, boosters, aromatase inhibitors, fertility medicine, or steroids because of one result. Get prompt care for sudden testicular pain, fast new androgen signs, a severe headache, or vision changes. Pregnancy with unintended androgen exposure and serious new nerve, breathing, or chest symptoms also need prompt care.

06

What to save from the testosterone report

Keep these together

  • Exact test name: total, free, calculated free, or bioavailable
  • Value, unit, and printed reference interval
  • Laboratory and assay or method if shown
  • Collection date, clock time, and usual wake time
  • Fasting status and instructions followed
  • Acute illness, surgery, poor intake, or recovery timing
  • Age, sex, and pubertal stage when assessed
  • Menstrual, menopause, pregnancy, postpartum, and fertility context when relevant
  • Symptoms or signs, onset, and speed of change
  • Medicines, hormone products, supplements, and last use
  • SHBG, free testosterone, LH, FSH, prolactin, DHEA-S, or other paired results
  • Clinician interpretation and the next decision

Question for the visit

“Was the correct testosterone fraction measured at the right time with a suitable assay, does the result need confirmation, and what next result would change the conclusion?”
07

Sources for Testosterone Blood Test

01
MedlinePlus, Testosterone Levels Test

Test types, uses across males, females, and children, blood-draw procedure, preparation, and result limits.

02
MedlinePlus Medical Encyclopedia, Testosterone

Current US example ranges, morning collection, repeat-low context, and causes of high or low results.

03
Endocrine Society, Testosterone Therapy in Men With Hypogonadism

Symptoms plus consistently low testing, morning fasting confirmation, assay quality, cause evaluation, and treatment boundaries.

04
Endocrine Society, 2026 Testosterone Replacement Therapy Statement

Current diagnostic threshold context, two-test requirement, reversible causes, assay standardization, and treatment evidence limits.

05
American Urological Association, Testosterone Deficiency Guideline

Two early-morning tests, below-300 limit, acute illness, variation, and diagnostic pathway.

06
CDC Hormone Standardization Program, Certified Assays, April 2026

Current total-testosterone assay certification range and analytical performance criterion.

07
Mayo Clinic Laboratories, Total Testosterone by LC-MS/MS

Method-specific adult, pediatric, and Tanner-stage intervals.

08
Labcorp, Total Testosterone for Women, Children, and Hypogonadal Males

LC-MS/MS specimen details and age-, sex-, and Tanner-stage intervals.

09
University Hospitals of North Midlands, Testosterone

Current UK 9 am fasting collection, acute-illness boundary, sex-specific uses, and paired hormones.

10
Royal United Hospitals Bath, Free Testosterone, updated April 2026

UK repeat 9 am fasting pathway and calculated free-testosterone context.

11
Healthdirect Australia, Testosterone Blood Test

Australian patient-facing preparation, morning collection, repeat-low context, and result limits.

12
Queensland Health, Male Hypogonadism and Infertility

Australian morning collection and paired total, free, SHBG, LH, and FSH pathway.

13
SA Pathology, Official Reference Intervals, 2025

Current Australian age- and sex-specific total-testosterone examples.

14
International Evidence-based PCOS Guideline, 2023

Female androgen-excess testing, assay quality, contraception context, and rapid-progression boundary.

15
Travison et al., Journal of Clinical Endocrinology and Metabolism, 2017

Harmonized reference values from 9,054 community-dwelling men.

16
French et al., Clinical Mass Spectrometry, 2019

Comparison and harmonization of four validated LC-MS/MS testosterone assays.

17
Teede et al., Fertility and Sterility, 2023

International PCOS recommendations for biochemical hyperandrogenism.

18
Anawalt et al., JAMA, 2026

Current adult male hypogonadism diagnosis, prevalence, reversible causes, testing, and treatment review.

19
Wainwright et al., Journal of Endocrinological Investigation, 2026

Age-continuous female reference research in 5,323 selected capillary samples and its conflict-of-interest context.

20
Knight et al., Psychological Science, 2026

Preregistered randomized 1,000-man cognitive-reflection replication and brain-fog claim boundary.

21
Friedl et al., Journal of the Endocrine Society, 2026

Visceral-adiposity phenotype and reversible-cause context for low testosterone.

See each claim's sources

interpretation

A 2026 JAMA review confirms that adult male hypogonadism is a clinical syndrome requiring consistently low morning results and compatible signs or symptoms.